References

Akksilp, S., W. Wattanaamornkiat, W. Kittikraisak, S. Nateniyom, S. Rienthong, C. Sirinak, K. Ngamlert, W. Mankatittham, W. Sattayawuthipong, S. Sumnapun, N. Yamada, P. Monkongdee, A. Anuwatnonthakate, C. Burapat, C. D. Wells, J. W. Tappero, and J. K. Varma. 2009. Multi-drug resistant TB and HIV in Thailand: Overlapping, but not independently associated risk factors. Southeast Asian Journal of Tropical Medicine and Public Health 40(6):1264-1278.

Andrews, R. H., S. Devadatta, W. Fox, S. Radhakrishna, C. V. Ramakrishnan, and S. Velu. 1960. Prevalence of tuberculosis among close family contacts of tuberculous patients in South India, and influence of segregation of the patient on early attack rate. Bulletin of the World Health Organization 23:463-510.

Arora, V. K., R. Sarin, R. Singla, U. K. Khalid, K. Mathuria, N. Singla, and V. P. Myneedu. 2007. DOTS-Plus for patients with multidrug-resistant tuberculosis in India: Early results after three years. Indian Journal of Chest Diseases and Allied Sciences 49:75-79.

Batra, S. 2011. Dramatic Results in TB Treatment: Building a Low Cost, Effective, Scalable and Replicable Model. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India.

Becerra, M. C., S. C. Appleton, M. F. Franke, K. Chalco, F. Arteaga, J. Bayona, M. Murray, S. S. Atwood, and C. D. Mitnick. 2011. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: A retrospective cohort study. Lancet 377(9760):147-152.

Behera, D. 2011. HIV-MDR TB Co-Infection in India. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India.

Boehme, C. C., P. Nabeta, D. Hillemann, M. P. Nicol, S. Shenai, F. Krapp, J. Allen, R. Tahirli, R. Blakemore, R. Rustomjee, A. Milovic, M. Jones, S. M. O’Brien, D. H. Persing, S. Ruesch-Gerdes, E. Gotuzzo, C. Rodrigues, D. Alland, and M. D. Perkins. 2010. Rapid molecular detection of tuberculosis and rifampicin resistance. New England Journal of Medicine 363(11):1005-1015.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 121
References Akksilp, S., W. Wattanaamornkiat, W. Kittikraisak, S. Nateniyom, S. Rienthong, C. Sirinak, K. Ngamlert, W. Mankatittham, W. Sattayawuthipong, S. Sumnapun, N. Yamada, P. Monkongdee, A. Anuwatnonthakate, C. Burapat, C. D. Wells, J. W. Tappero, and J. K. Varma. 2009. Multi-drug resistant TB and HIV in Thailand: Overlapping, but not independently associated risk factors. Southeast Asian Journal of Tropical Medicine and Public Health 40(6):1264-1278. Andrews, R. H., S. Devadatta, W. Fox, S. Radhakrishna, C. V. Ramakrishnan, and S. Velu. 1960. Prevalence of tuberculosis among close family contacts of tuberculous patients in South India, and influence of segregation of the patient on early attack rate. Bulletin of the World Health Organization 23:463-510. Arora, V. K., R. Sarin, R. Singla, U. K. Khalid, K. Mathuria, N. Singla, and V. P. Myneedu. 2007. DOTS-Plus for patients with multidrug-resistant tuberculosis in India: Early results after three years. Indian Journal of Chest Diseases and Allied Sciences 49:75-79. Batra, S. 2011. Dramatic Results in TB Treatment: Building a Low Cost, Effective, Scalable and Replicable Model. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India. Becerra, M. C., S. C. Appleton, M. F. Franke, K. Chalco, F. Arteaga, J. Bayona, M. Murray, S. S. Atwood, and C. D. Mitnick. 2011. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: A retrospective cohort study. Lancet 377(9760):147-152. Behera, D. 2011. HIV-MDR TB Co-Infection in India. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India. Boehme, C. C., P. Nabeta, D. Hillemann, M. P. Nicol, S. Shenai, F. Krapp, J. Allen, R. Tahirli, R. Blakemore, R. Rustomjee, A. Milovic, M. Jones, S. M. O’Brien, D. H. Persing, S. Ruesch-Gerdes, E. Gotuzzo, C. Rodrigues, D. Alland, and M. D. Perkins. 2010. Rapid molecular detection of tuberculosis and rifampicin resistance. New England Journal of Medicine 363(11):1005-1015. 121

OCR for page 121
122 DRUG-RESISTANT TUBERCULOSIS IN INDIA Borrell, S., and S. Gagneux. 2009. Infectiousness, reproductive fitness and evolution of drug- resistant Mycobacterium tuberculosis. International Journal of Tuberculosis and Lung Disease 13(12):1456-1466. Brooks, S. M., N. L. Lassiter, and E. C. Young. 1973. A pilot study concerning the infection risk of sputum positive tuberculosis patients on chemotherapy. American Review of Respiratory Disease 108(4):799-804. Bwanga, F., S. Hoffner, M. Haile, and M. L. Joloba. 2009. Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis. BMC Infectious Diseases 9:67. Coker, R. J. 2004. Review: Multidrug-resistant tuberculosis: Public health challenges. Tropical Medicine and International Health 9(1):25-40. Deivanayagam, C. N., S. Rajasekaran, R. Venkatesan, A. Mahilmaran, P. R. Ahmed, S. Annadurai, S. Kumar, C. Chandrasekar, N. Ravichandran, and R. Pencillaiah. 2002. Prevalence of acquired MDR-TB and HIV co-infection. Indian Journal of Chest Diseases and Allied Sciences 44(4):237-242. Dewan, P. K., D. Gupta, B. G. Williams, R. Thakur, D. Bachani, A. Khera, D. F. Wares, S. Sahu, D. C. Reddy, N. Raizada, and L. S. Chauhan. 2010. National estimate of HIV se- roprevalence among tuberculosis patients in India. International Journal of Tuberculosis and Lung Disease 14(2):247-249. Drobac, P. C., J. S. Mukherjee, J. K. Joseph, C. Mitnick, J. J. Furin, H. del Castillo, S. S. Shin, and M. C. Becerra. 2006. Community-based therapy for children with multidrug- resistant tuberculosis. Pediatrics 117(6):2022-2029. Drobniewski, F., I. Eltringham, C. Graham, J. G. Magee, E. G. Smith, and B. Watt. 2002. A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax 57(9):810-816. Dye, C., and B. G. Williams. 2010. The population dynamics and control of tuberculosis. Science 328(5980):856-861. Escombe, A. R., D. A. Moore, R. H. Gilman, W. Pan, M. Navincopa, E. Ticona, C. Martínez, L. Caviedes, P. Sheen, A. Gonzalez, C. J. Noakes, J. S. Friedland, and C. A. Evans. 2008. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Medicine 5(9):e188. Fairlie, L., N. C. Beylis, G. Reubenson, D. P. Moore, and S. A. Madhi. 2011. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: A cross sectional study. BMC Infectious Diseases 11:28. Fiegel, J., L. Garcia-Contreras, M. Thomas, J. VerBerkmoes, K. Elbert, A. Hickey, and D. Edwards. 2008. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin. Pharmaceutical Research 25(4):805-811. Frieden, T. R., P. I. Fujiwara, R. M. Washko, and M. A. Hamburg. 1995. Tuberculosis in New York City—Turning the tide. New England Journal of Medicine 333(4):229-233. Gagneux, S., C. D. Long, P. M. Small, T. Van, G. K. Schoolnik, and B. J. Bohannan. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312(5782):1944-1946. Gandhi, N. R., A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, J. Andrews, and G. Friedland. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368(9547):1575-1580. Gandhi, N. R., S. Shah, J. R. Andrews, V. Vella, A. P. Moll, M. Scott, D. Weissman, C. Marra, U. G. Lalloo, and G. H. Friedland on behalf of the Tugela Ferry Care and Research (TF CARES) Collaboration. 2010. HIV coinfection in multidrug- and extensively drug- resistant tuberculosis results in high early mortality. American Journal of Respiratory and Critical Care Medicine 181:80-86.

OCR for page 121
123 REFERENCES Garcia-Contreras, L., J. Fiegel, M. J. Telko, K. Elbert, A. Hawi, M. Thomas, J. VerBerkmoes, W. A. Germishuizen, P. B. Fourie, A. J. Hickey, and D. Edwards. 2007. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Antimicrobial Agents and Chemotherapy 51(8):2830-2836. Government of India. 2001. Census Data 2001; India at a Glance; Broad Age Groups. http://www.censusindia.gov.in/Census_Data_2001/India_at_glance/broad.aspx (accessed March 22, 2012). Government of India. 2011. Provisional Population Totals. Paper 1 Chapter 3: Size, Growth Rate and Distribution of Population; Census 2011. http://www.censusindia.gov.in/2011- prov-results/prov_results_paper1_india.html (accessed March 22, 2012). Ha, D. T., N. T. Lan, M. Wolbers, T. N. Duong, N. D. Quang, T. Thi Van Thinh, L. Thi Hong Ngoc, N. Thi Ngoc Anh, T. Van Quyet, N. Thi Bich Tuyen, V. Thi Ha, J. Day, H. Thi Thanh Hang, V. S. Kiet, N. Thi Nho, D. V. Hoa, N. H. Dung, N. Huu Lan, J. Farrar, and M. Caws. 2009. Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS ONE 4(12):e8341. Hazarika, I. 2011. Role of private sector in providing tuberculosis care: Evidence from a population-based survey in India. Journal of Global Infectious Diseases 3(1):19-24. Heller, T., R. J. Lessells, C. G. Wallrauch, T. Bärnighausen, G. S. Cooke, L. Mhlongo, I. Master, and M. L. Newell. 2010. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa. International Journal of Tuberculosis and Lung Disease 14(4):420-426. ICMR (Indian Council of Medical Research). 1968. Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. I: Findings in urban clinics among patients giving no history of previous che- motherapy. Indian Journal of Medical Research 56:1617-1630. ICMR. 1969. Prevalence of drug resistance in patients with pulmonary tuberculosis present- ing for the first time with symptoms at chest clinics in India. II. Findings in urban clinics among all patients, with or without history of previous chemotherapy. Indian Journal of Medical Research 57:823-835. IIPS (International Institute for Population Sciences) and Macro International. 2007. National Family Health Survey (NFHS-3), 2005-06: India: Volume I. Mumbai: IIPS. IOM (Institute of Medicine). 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge. Washington, DC: The National Academies Press. IOM. 2011a. The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local Challenges and Solutions. Washington, DC: The National Academies Press. IOM. 2011b. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective. Washington, DC: The National Academies Press. Jackson, S., A. C. Sleigh, G. J. Wang, and X. L. Liu. 2006. Poverty and the economic ef- fects of TB in rural China. International Journal of Tuberculosis and Lung Disease 10(10):1104-1110. Kawai, V., G. Soto, R. H. Gilman, C. T. Bautista, L. Caviedes, L. Huaroto, E. Ticona, J. Ortiz, M. Tovar, V. Chavez, R. Rodriguez, A. R. Escombe, and C. A. Evans. 2006. Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. American Journal of Tropical Medicine and Hygiene 75(6):1027-1033. Keshavjee, S. 2011a. Setting the Stage: Global Challenges in Drug-Resistant Tuberculosis and Potential Solutions. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 18, New Delhi, India.

OCR for page 121
124 DRUG-RESISTANT TUBERCULOSIS IN INDIA Keshavjee, S. 2011b. Overview of Global Drug-Resistant Tuberculosis Burden. Speaker presentation of slides developed by Matteo Zignol (WHO/STOP TB Department) at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 18, New Delhi, India. Keshavjee, S., I. Y. Gelmanova, P. E. Farmer, S. P. Mishustin, A. K. Strelis, Y. G. Andreev, A. D. Pasechnikov, S. Atwood, J. S. Mukherjee, M. L. Rich, J. L. Furin, E. A. Nardell, J. Y. Kim, and S. S. Shin. 2008. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: A retrospective cohort study. Lancet 372(9647):1403-1409. Keshavjee, S., and K. Seung. 2008. Stemming the Tide of Multidrug-Resistant Tuberculo- sis: Major Barriers to Addressing the Growing Epidemic. http://www.iom.edu/~/media/ Files/Activity%20Files/Research/DrugForum/IOM_MDRTB_whitepaper_2009_01_14_ FINAL_Edited.pdf (accessed September 15, 2011). Khan, A. 2011. Mobile Technology to Improve Drug-Resistant TB Control and Management in Karachi. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India. Kim, S. J., M. A. Espinal, C. Abe, G. H. Bai, F. Boulahbal, L. Fattorin, C. Gilpin, S. Hoffner, K. M. Kam, N. Martin-Casabona, L. Rigouts, and V. Vincent. 2004. Is second-line anti- tuberculosis drug susceptibility testing reliable? International Journal of Tuberculosis and Lung Disease 8(9):1157-1158. Krishnamurthy, A., C. Rodrigues, and A. P. Mehta. 2002. Rapid detection of rifampicin resistance in M. tuberculosis by phage assay. Indian Journal of Medical Microbiology 20:211-214. Llerena, C., S. E. Fadul, M. C. Garzón, G. Mejía, D. L. Orjuela, L. M. García, H. B. Álvarez, and F. J. Ruiz. 2010. Drug-resistant Mycobacterium tuberculosis in children under 15 years. Biomedica 30(3):362-370. Loudon, R. G., R. A. Frantz Jr., and C. A. LeMaistre. 1969. Laboratory for the study of my- cobacterial aerosols. American Review of Respiratory Disease 100(2):160-164. Marras, T. K., J. Wilson, E. E. Wang, M. Avendano, and J. W. Yang. 2003. Tuberculosis among Tibetan refugee claimants in Toronto: 1998 to 2000. Chest 124(3):915-921. Menzies, D. 1997. Effect of treatment on contagiousness of patients with active pulmonary tuberculosis. Infection Control and Hospital Epidemiology 18(8):582-586. Mitnick, C. D., J. Bayona, E. Palacios, S. Shin, J. Furin, F. Alcántara, E. Sánchez, M. Sarria, M. Becerra, M. C. Fawzi, S. Kapiga, D. Neuberg, J. H. Maguire, J. Y. Kim, and P. Farmer. 2003. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine 348(2):119-128. Mitnick, C. D., S. S. Shin, K. J. Seung, M. L. Rich, S. S. Atwood, J. J. Furin, G. M. Fitzmaurice, F. A. Alcantara Viru, S. C. Appleton, J. N. Bayona, C. A. Bonilla, K. Chalco, S. Choi, M. F. Franke, H. S. Fraser, D. Guerra, R. M. Hurtado, D. Jazayeri, K. Joseph, K. Llaro, L. Mestanza, J. S. Mukherjee, M. Muñoz, E. Palacios, E. Sanchez, A. Sloutsky, and M. C. Becerra. 2008. Comprehensive treatment of extensively drug-resistant tuberculosis. New England Journal of Medicine 359(6):563-574. Mohapatra, P. R. 2010. Lesson from surveillance of drug-resistant tuberculosis in Gujarat. Indian Journal of Medical Research 132:103-104. Mondal, R., and A. Jain. 2007. Extensively drug-resistant Mycobacterium tuberculosis iso- lates, India [letter]. Emerging Infectious Diseases 13(9):1429-1431. MSF (Médecins Sans Frontières) and IUATLD (International Union Against Tuberculosis and Lung Disease). 2011. DR-TB Drugs Under the Microscope: Sources and Prices for Drug-Resistant Tuberculosis Medicines. http://www.msfaccess.org/content/dr-tb-drugs- under-microscope (accessed November 16, 2011).

OCR for page 121
125 REFERENCES Myneedu, V. P., P. Visalakshi, A. K. Verma, D. Behera, and M. Bhalla. 2011. Prevalence of XDR TB cases—A retrospective study from a tertiary care TB hospital. International Journal of Tuberculosis and Lung Disease 58(2):54-59. Narayanan, S., S. Swaminathan, P. Supply, S. Shanmugam, G. Narendran, L. Hari, R. Ramachandran, C. Locht, M. S. Jawahar, and P. R. Narayanan. 2010. Impact of HIV infection on the recurrence of tuberculosis in South India. Journal of Infectious Diseases 201(5):691-703. Nardell, E., and A. Dharmadhikari. 2010. Turning off the spigot: Reducing drug-resistant tu- berculosis transmission in resource-limited settings. International Journal of Tuberculosis and Lung Disease 14(10):1233-1243. Nelson, L. J., Y. Naik, K. Tsering, and J. P. Cegielski. 2005. Population-based risk factors for tuberculosis and adverse outcomes among Tibetan refugees in India, 1994-1996. Inter- national Journal of Tuberculosis and Lung Disease 9(9):1018-1026. Paramasivan, C. N., E. Lee, K. Kao, M. Mareka, G. Kubendiran, T. A. Kumar, S. Keshavjee, H. Satti, G. Alabi, M. Raviglione, and G. Roscigno. 2010. Experience establishing tu- berculosis laboratory capacity in a developing country setting. International Journal of Tuberculosis and Lung Disease 14(1):59-64. Paramasivan, C. N., and P. Venkataraman. 2004. Drug resistance in tuberculosis in India. Indian Journal of Medical Research 120(4):377-386. Pereira, M., S. Tripathy, V. Inamdar, K. Ramesh, M. Bhavsar, A. Date, R. Iyyer, A. Acchammachary, S. Mehendale, and A. Risbud. 2005. Drug resistance pattern of Myco- bacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian Journal of Medical Research 121(4):235-239. Planning Commission of India. 2011. High Level Expert Group Report on Universal Health Coverage for India. http://planningcommission.nic.in/reports/genrep/rep_uhc0812.pdf (accessed April 13, 2012). Ramachandran, P., S. Nalini, V. Chandrasekar, P. V. Dave, A. S. Sanghvi, F. Wares, C. N. Paramasivan, P. R. Narayanan, S. Sahu, M. Parmar, S. Chadha, P. Dewan, and L. S. Chauhan. 2009. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. International Journal of Tuberculosis and Lung Disease 13(9):1154-1160. Ramachandran, P., and R. Prabhakar. 1992. Defaults, defaulter action and retrieval of pa- tients during studies on tuberculous meningitis in children. Tubercle and Lung Disease 73(3):170-173. Riley, R. L., C. C. Mills, W. Nyka, N. Weinstock, P. B. Storey, L. U. Sultan, M. C. Riley, and W. F. Wells. 1959. Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. American Journal of Epidemiology 142(1):3-14. Riley, R. L., C. C. Mills, F. O’Grady, L. U. Sultan, F. Wittstadt, and D. N. Shivpuri. 1962. Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: Comparative infectiousness of different patients. American Review of Respiratory Dis- ease 85:511-525. RNTCP Status Report. 2007. TB India 2007. Central TB Division, DGHS, MoHFW. New Delhi: Government of India. RNTCP Status Report. 2011. TB India 2011. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. New Delhi: Government of In- dia. http://tbcindia.nic.in/pdfs/RNTCP%20TB%20India%202011.pdf (accessed March 21, 2012). Robledo, J., G. I. Mejia, L. Paniagua, A. Martin, and A. Guzmán. 2008. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method. International Journal of Tuberculosis and Lung Disease 12(12):1482-1484.

OCR for page 121
126 DRUG-RESISTANT TUBERCULOSIS IN INDIA Rodrigues, C., J. Jani, S. Shenai, P. Thakkar, S. Siddiqi, and A. Mehta. 2008. Drug sus- ceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. International Journal of Tuberculosis and Lung Disease 12(12):1449-1455. Rouillon, A., S. Perdrizet, and R. Parrot. 1976. Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle 57(4):275-299. Sachdeva, K. S. 2011. Overview of Drug-Resistant TB in India and National Scale Up of MDR TB Diagnosis and Treatment. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 18, New Delhi, India. Satyanarayana, S., S. A. Nair, S. S. Chadha, R. Shivashankar, G. Sharma, S. Yadav, S. Mohanty, V. Kamineni, N. C. Wilson, A. D. Harries, and P. K. Dewan. 2011. From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PLoS ONE 6(9):e24160. Saxena, P. 2011. Implementation of MDR-TB Programme in India—Successes and Chal- lenges in Second-Line Anti-TB Drugs Management. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India. Schaaf, H. S., B. J. Marais, A. C. Hesseling, W. Brittle, and P. R. Donald. 2009. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa—An upward trend. American Journal of Public Health 99(8):1486-1490. Schaaf, H. S., K. Shean, and P. R. Donald. 2003. Culture confirmed multidrug resistant tuberculosis: Diagnostic delay, clinical features, and outcome. Archives of Disease in Childhood 88(12):1106-1111. Shanmugam, S., N. Selvakumar, and S. Narayanan. 2011. Drug resistance among different genotypes of Mycobacterium tuberculosis isolated from patients from Tiruvallur, South India. Infection, Genetics and Evolution 11(5):980-986. Sharma, S. K., N. George, T. Kadhiravan, P. K. Saha, H. K. Mishra, and M. Hanif. 2009. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug- resistant tuberculosis: A retrospective hospital-based study. Indian Journal of Medical Research 130:392-395. Sharma, S. K., G. Kaushik, B. Jha, N. George, S. K. Arora, D. Gupta, U. Singh, M. Hanif, and R. P. Vashisht. 2011a. Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian Journal of Medical Research 133(3):308-311. Sharma, S. K., S. Kumar, P. K. Saha, N. George, S. K. Arora, D. Gupta, U. Singh, M. Hanif, and R. P. Vashisht. 2011b. Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients. Indian Journal of Medical Research 133(3):312-315. Sharma, S. K., R. Sarin, U. K. Khalid, N. Singla, P. P. Sharma, and D. Behera. 2008. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India. International Journal of Tuberculosis and Lung Disease 12(1):74-80. Shin, S., J. Furin, J. Bayona, K. Mate, J. Y. Kim, and P. Farmer. 2004. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Social Science and Medicine 59:1529-1539. Shin, S. S., A. D. Pasechnikov, I. Y. Gelmanova, G. G. Peremitin, A. K. Strelis, Y. G. Andreev, V. T. Golubchikova, T. P. Tonkel, G. V. Yanova, M. Nikiforov, A. Yedilbayev, J. S. Mukherjee, J. J. Furin, D. J. Barry, P. E. Farmer, M. L. Rich, and S. Keshavjee. 2006. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. International Journal of Tuberculosis and Lung Disease 10(4):402-408. Singh, S., M. M. Sankar, and K. Gopinath. 2007. High rate of extensively drug-resistant tu- berculosis in Indian AIDS patients. AIDS 21(17):2345-2347.

OCR for page 121
127 REFERENCES Suchindran, S., E. S. Brouwer, and A. Van Rie. 2009. Is HIV infection a risk factor for multi- drug resistant tuberculosis? A systematic review. PLoS ONE 4(5):e5561. Swaminathan, S. 2011. Drug Resistant Tuberculosis in Children. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India. Swaminathan, S., C. N. Paramasivan, C. Ponnuraja, S. Iliayas, S. Rajasekaran, and P. R. Narayanan. 2005. Anti-tuberculosis drug resistance tuberculosis in patients with HIV and tuberculosis in South India. International Journal of Tuberculosis and Lung Disease 9(8):896-900. TB Alliance (Global Alliance for TB Drug Development). 2007. Pathway to Patients: Charting the Dynamics of the Global TB Drug Market. India Case Study. http://www.tballiance. org/downloads/publications/study07/India_Case_Study.pdf (accessed March 26, 2012). Treatment Action Group. 2011. Tuberculosis Research & Development: 2011 Report on Tuberculosis Research Funding Trends, 2005-2010. http://www.stoptb.org/assets/ documents/resources/publications/acsm/TAG%20TB%20R&D%202011%20Report. pdf (accessed October 26, 2011). Trindade, S., A. Sousa, K. B. Xavier, F. Dionisio, M. G. Ferreira, and I. Gordo. 2009. Positive epistasis drives the acquisition of multidrug resistance. PLoS Genetics 5(7):e1000578. Truong, D. H., L. L. Hedemark, J. K. Mickman, L. B. Mosher, S. E. Dietrich, and P. W. Lowry. 1997. Tuberculosis among Tibetan immigrants from India and Nepal in Minnesota, 1992-1995. Journal of the American Medical Association 277(9):735-738. Udwadia, Z. F., R. A. Amale, K. K. Ajbani, and C. Rodrigues. 2012. Totally drug-resistant tuberculosis in India. Clinical Infectious Diseases 54(4):579-581. Udwadia, Z. F., L. M. Pinto, M. W. Uplekar. 2010. Tuberculosis management by private practitioners in Mumbai, India: Has anything changed in two decades? PLoS ONE 5(8):e12023. Van Deun, A., A. Wright, M. Zignol, K. Weyer, and H. L. Rieder. 2011. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories. International Journal of Tuberculosis and Lung Disease 15(1):116-124. WHA (World Health Assembly). 2009. Prevention and Control of Multidrug-Resistant Tu- berculosis and Extensively Drug-Resistant Tuberculosis. http://apps.who.int/gb/ebwha/ pdf_files/A62/A62_R15-en.pdf (accessed December 6, 2011). WHO (World Health Organization). 1996. Groups at Risk: WHO Report on the Tuberculosis Epidemic. Geneva, Switzerland: WHO. WHO. 2008. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: Emergency Update 2008. Geneva, Switzerland: WHO Press. WHO. 2010a. 2010/2011 Tuberculosis Global Facts. http://www.who.int/tb/publica- tions/2010/factsheet_tb_2010.pdf (accessed September 15, 2011). WHO. 2010b. Global Tuberculosis Control: WHO Report 2010. http://www.who.int/tb/ publications/global_report/2010/en/index.html (accessed September 18, 2011). WHO. 2010c. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. http://www.who.int/tb/features_archive/m_xdrtb_ facts/en/index.html (accessed November 22, 2011). WHO. 2011a. Global Tuberculosis Control: WHO Report 2011. http://whqlibdoc.who.int/ publications/2011/9789241564380_eng.pdf (accessed November 15, 2011). WHO. 2011b. Towards Universal Access to Diagnosis and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis by 2015: WHO Progress Report 2011. http://www.who.int/tb/publications/2011/mdr_report_2011/en/index.html (accessed No- vember 22, 2011).

OCR for page 121
128 DRUG-RESISTANT TUBERCULOSIS IN INDIA WHO. 2011c. Guidelines for the Programmatic Management of Drug-Resistant Tuberculo- sis: 2011 Update. http://www.who.int/tb/challenges/mdr/programmatic_guidelines_for_ mdrtb/en/index.html (accessed December 5, 2011). World Economic Forum. 2008. Tackling Tuberculosis: The Business Response. https:// members.weforum.org/pdf/GHI/TB.pdf (accessed April 19, 2012). Wright, A., M. Zignol, A. Van Deun, D. Falzon, S. R. Gerdes, K. Feldman, S. Hoffner, F. Drobniewski, L. Barrera, D. van Soolingen, F. Boulabhal, C. N. Paramasivan, K. M. Kam, S. Mitarai, P. Nunn, M. Raviglione, and Global Project on Anti-Tuberculosis Drug Resistance Surveillance. 2009. Epidemiology of antituberculosis drug resistance 2002-07: An updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveil- lance. Lancet 373(9678):1861-1873. Yadav, P. 2011. MDR-TB: Challenges in Drug Supply Chain Logistics. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India. Zignol, M., W. van Gemert, D. Falzon, C. Sismanidis, P. Glaziou, K. Floyd, and M. Raviglione. 2012. Surveillance of anti-tuberculosis drug resistance in the world: An updated analysis, 2007-2010. Bulletin World Health Organization 90:111D-119D.